(Q67213435)
Statements
Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in Parkinson's disease patients: a double-blind single-dose study (English)
R Leiguarda
R Pikielny
scientific article published on 01 April 1997
No description defined